Healthcare / Health Information ServicesNasdaqGS
$25.98
+0.02 (+0.08%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 31% · confianza 25%
FCF escenarios
weak_data · normalized FCF $13.0M · quality 42.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$390M
P/E
89.6x
↑EV/EBITDA
12.2x
↑ROE
2.4%
↑Gross Margin
53.0%
↑Debt/Equity
0.94
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
+6.4%
FCF CAGR
+5.9%
FCF margin
5.7%
FCF / Net income
4.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $346.8M · net income $4.4M · FCF $19.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $346.8M | $346.8M | $342.2M | $337.0M | $326.6M | $280.6M | $264.5M | $274.6M | $280.4M | $276.9M | $267.3M | $182.2M | $204.7M | $200.9M | $183.3M | $173.5M | $153.2M | $127.7M |
| Net Income | $4.4M | $4.4M | $-20.9M | $-48.1M | $15.9M | $18.4M | $14.2M | $20.5M | $17.6M | $-17.4M | $3.9M | $18.3M | $32.9M | $32.7M | $30.0M | $25.8M | $18.7M | $15.2M |
| EBITDA | $42.5M | $42.5M | $34.3M | $-18.6M | $47.7M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS | 0.29 | 0.29 | -1.55 | -3.15 | 1.08 | 1.26 | 0.98 | 1.43 | 1.26 | -1.27 | 0.29 | 1.62 | 2.94 | 2.95 | 2.71 | 2.34 | 1.71 | 1.39 |
| Gross Margin | 53.0% | 53.0% | 50.6% | 47.9% | 49.0% | 50.2% | 51.5% | 52.5% | 53.4% | 53.2% | 50.0% | 51.9% | 55.7% | 46.7% | 44.0% | 45.8% | 42.0% | 41.7% |
| Operating Margin | 6.0% | 6.0% | 1.9% | -2.2% | 7.0% | 8.8% | 8.0% | 9.0% | 8.9% | -1.7% | 5.4% | 13.8% | 24.2% | 25.0% | 22.5% | 23.8% | 19.0% | 18.3% |
| Net Margin | 1.3% | 1.3% | -6.1% | -14.3% | 4.9% | 6.6% | 5.4% | 7.5% | 6.3% | -6.3% | 1.5% | 10.1% | 16.1% | 16.3% | 16.4% | 14.9% | 12.2% | 11.9% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.94 | 0.94 | 1.05 | 1.10 | 0.64 | 0.43 | 0.37 | 0.54 | 0.78 | 1.00 | 0.93 | 0.00 | — | — | — | — | — | — |
| Current Ratio | 1.78 | 1.78 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $19.8M | $19.8M | $13.0M | $-22.3M | $13.0M | $46.8M | $45.8M | $41.8M | $23.0M | $22.9M | $2.1M | $30.4M | $37.5M | $25.4M | $27.8M | $22.7M | $14.5M | $8.0M |
| Returns | ||||||||||||||||||
| ROE | 2.4% | 2.4% | -12.5% | -26.2% | 6.8% | 8.3% | 7.1% | 11.1% | 11.0% | -12.8% | 2.5% | 24.3% | 40.8% | 47.4% | 52.4% | 45.0% | 40.3% | 35.6% |
| Valuation | ||||||||||||||||||
| P/E | 89.59 | 89.59 | — | — | 25.34 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 12.21 | 12.21 | 13.36 | — | 11.17 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 2.12 | 2.12 | 1.77 | 0.77 | 1.70 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | 1.4% | 1.4% | 1.6% | 3.2% | — | 6.1% | -3.7% | -2.1% | 1.3% | 3.6% | 46.7% | -11.0% | 1.9% | 9.6% | 5.7% | 13.2% | 20.0% | — |
| EPS Growth | 118.7% | 118.7% | 50.8% | -391.7% | — | 28.6% | -31.5% | 13.5% | 199.2% | -537.9% | -82.1% | -44.9% | -0.3% | 8.9% | 15.8% | 36.8% | 23.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
99.6%
EPS terminal req.
$2.31
Spread vs growth
19.1%
5Y implied EPS CAGR
57.3%
EPS terminal req.
$2.79
Spread vs growth
61.4%
10Y implied EPS CAGR
31.5%
EPS terminal req.
$4.49
Spread vs growth
87.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+9.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.55 → 0.29
Residual
+9.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.